The concept of ventricular mural antagonism has been introduced recently, where the main constrictive forces in the ventricular myocardium are complemented by a dilatory force component.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
May 3, 2018
A somewhat delayed publication of a 2016 paper that discusses important trends in cardiac transplanation in the light of increasing use of ECMO.
In Global News: Nuts for Heart Health, Immunotherapy Prior to NSCLC Surgery, and Treatment for Children With CHD
April 20, 2018
Patient Care The Chinese Red Cross has announced that 25 Afghan children with congenital heart disease will receive free medical treatment in China.
In Global News: Raising Esophageal Cancer Awareness, Healthy Eating for Healthy Arteries, and Avoiding TAVR-Induced Coronary Obstruction
April 6, 2018
Patient Care A baby in Taiwan is the third-lightest to have undergone repair of a type A interrupted aortic arch and aortopulmonary window.
April 3, 2018
Gosev and colleagues evaluated the baseline characteristics and outcomes in 156 patients from 12 centers who survived at least four years on left ventricular assist device (LVAD) support. Among this group of patients, mean survival was 7.1 years (95% CI 6.7 to 7.5 years).
March 27, 2018
A brief readable editorial on a retrospective analysis of the costs of coronary artery bypass grafting in Virginia, USA, which suggests the value of enhanced recovery in coronopathy.
March 12, 2018
An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with the latest technology, reflected in the lower LDH measurements, there was bafflingly no improvement in survival.
March 1, 2018
A 16-year retrospective analysis of cardiac transplantation outcomes, recommending cold ischemic times of less than two hours for older donors.
Selective Implantation of Durable Left Ventricular Assist Devices as Primary Therapy for Refractory Cardiogenic Shock
February 28, 2018
A retrospective Mount Sinai small series on selective emergent implantation of long-term ventricular assist devices in cardiogenic shock. It challenges the traditional concept of short-term stabilisation with ECMO or short-term support, and is likely to generate criticism and discussions.
In Global News: The Benefits of Exercise Before Surgery, Heart Valve Updates, and Studying Innovative HLHS Therapies
February 16, 2018